Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 33

1.

Altered expression of renin-angiotensin system receptors throughout colorectal adenoma-adenocarcinoma sequence.

Beitia M, Solano-Iturri JD, Errarte P, Sanz B, Perez I, Etxezarraga MC, Loizate A, Asumendi A, Larrinaga G.

Int J Med Sci. 2019 Jun 2;16(6):813-821. doi: 10.7150/ijms.32599. eCollection 2019.

2.

Imaging Mass Spectrometry-Based Lipidomic Approach to Classification of Architectural Features in Nevi.

Garate J, Lage S, Fernández R, Velasco V, Abad B, Asumendi A, Gardeazabal J, Arroyo-Berdugo Y, Rodríguez MÁ, Artola JL, Zabalza I, Ochoa B, Fernández JA, Boyano MD.

J Invest Dermatol. 2019 Sep;139(9):2055-2058.e7. doi: 10.1016/j.jid.2019.01.031. Epub 2019 Mar 13. No abstract available.

PMID:
30878679
3.

Vitronectin and dermcidin serum levels predict the metastatic progression of AJCC I-II early-stage melanoma.

Ortega-Martínez I, Gardeazabal J, Erramuzpe A, Sanchez-Diez A, Cortés J, García-Vázquez MD, Pérez-Yarza G, Izu R, Luís Díaz-Ramón J, de la Fuente IM, Asumendi A, Boyano MD.

Int J Cancer. 2016 Oct 1;139(7):1598-607. doi: 10.1002/ijc.30202. Epub 2016 Jun 11.

4.

Metformin Induces Cell Cycle Arrest and Apoptosis in Drug-Resistant Leukemia Cells.

Rodríguez-Lirio A, Pérez-Yarza G, Fernández-Suárez MR, Alonso-Tejerina E, Boyano MD, Asumendi A.

Leuk Res Treatment. 2015;2015:516460. doi: 10.1155/2015/516460. Epub 2015 Nov 25.

5.

Involvement of ANXA5 and ILKAP in susceptibility to malignant melanoma.

Arroyo-Berdugo Y, Alonso S, Ribas G, Ibarrola-Villava M, Peña-Chilet M, Martínez-Cadenas C, Gardeazabal J, Ratón-Nieto JA, Sánchez-Díez A, Careaga JM, Pérez-Yarza G, Carretero G, Martín-González M, Gómez-Fernández C, Nagore E, Asumendi A, Boyano MD.

PLoS One. 2014 Apr 17;9(4):e95522. doi: 10.1371/journal.pone.0095522. eCollection 2014.

6.

Dihydroceramide accumulation and reactive oxygen species are distinct and nonessential events in 4-HPR-mediated leukemia cell death.

Apraiz A, Idkowiak-Baldys J, Nieto-Rementería N, Boyano MD, Hannun YA, Asumendi A.

Biochem Cell Biol. 2012 Apr;90(2):209-23. doi: 10.1139/o2012-001. Epub 2012 Mar 19.

7.

Evaluation of bioactive sphingolipids in 4-HPR-resistant leukemia cells.

Apraiz A, Idkowiak-Baldys JK, Boyano MD, Pérez-Yarza G, Hannun YA, Asumendi A.

BMC Cancer. 2011 Nov 7;11:477. doi: 10.1186/1471-2407-11-477.

8.

Terfenadine induces apoptosis and autophagy in melanoma cells through ROS-dependent and -independent mechanisms.

Nicolau-Galmés F, Asumendi A, Alonso-Tejerina E, Pérez-Yarza G, Jangi SM, Gardeazabal J, Arroyo-Berdugo Y, Careaga JM, Díaz-Ramón JL, Apraiz A, Boyano MD.

Apoptosis. 2011 Dec;16(12):1253-67. doi: 10.1007/s10495-011-0640-y.

9.

A customized pigmentation SNP array identifies a novel SNP associated with melanoma predisposition in the SLC45A2 gene.

Ibarrola-Villava M, Fernandez LP, Alonso S, Boyano MD, Peña-Chilet M, Pita G, Aviles JA, Mayor M, Gomez-Fernandez C, Casado B, Martin-Gonzalez M, Izagirre N, De la Rua C, Asumendi A, Perez-Yarza G, Arroyo-Berdugo Y, Boldo E, Lozoya R, Torrijos-Aguilar A, Pitarch A, Pitarch G, Sanchez-Motilla JM, Valcuende-Cavero F, Tomas-Cabedo G, Perez-Pastor G, Diaz-Perez JL, Gardeazabal J, Martinez de Lizarduy I, Sanchez-Diez A, Valdes C, Pizarro A, Casado M, Carretero G, Botella-Estrada R, Nagore E, Lazaro P, Lluch A, Benitez J, Martinez-Cadenas C, Ribas G.

PLoS One. 2011 Apr 29;6(4):e19271. doi: 10.1371/journal.pone.0019271.

10.

Cell-centric view of apoptosis and apoptotic cell death-inducing antitumoral strategies.

Apraiz A, Boyano MD, Asumendi A.

Cancers (Basel). 2011 Mar 3;3(1):1042-80. doi: 10.3390/cancers3011042.

11.

Histamine and histamine receptor antagonists in cancer biology.

Blaya B, Nicolau-Galmés F, Jangi SM, Ortega-Martínez I, Alonso-Tejerina E, Burgos-Bretones J, Pérez-Yarza G, Asumendi A, Boyano MD.

Inflamm Allergy Drug Targets. 2010 Jul;9(3):146-57. Review.

PMID:
20632959
12.

Comparative effects of six intraocular vital dyes on retinal pigment epithelial cells.

Morales MC, Freire V, Asumendi A, Araiz J, Herrera I, Castiella G, Corcóstegui I, Corcóstegui G.

Invest Ophthalmol Vis Sci. 2010 Nov;51(11):6018-29. doi: 10.1167/iovs.09-4916. Epub 2010 Jun 16.

PMID:
20554611
13.

Dihydroceramide desaturase activity is modulated by oxidative stress.

Idkowiak-Baldys J, Apraiz A, Li L, Rahmaniyan M, Clarke CJ, Kraveka JM, Asumendi A, Hannun YA.

Biochem J. 2010 Mar 29;427(2):265-74. doi: 10.1042/BJ20091589.

14.

Bexarotene activates the p53/p73 pathway in human cutaneous T-cell lymphoma.

Nieto-Rementería N, Pérez-Yarza G, Boyano MD, Apraiz A, Izu R, Díaz-Pérez JL, Asumendi A.

Br J Dermatol. 2009 Mar;160(3):519-26. doi: 10.1111/j.1365-2133.2008.08931.x. Epub 2008 Nov 25.

PMID:
19067706
15.

4-HPR-mediated leukemia cell cytotoxicity is triggered by ceramide-induced mitochondrial oxidative stress and is regulated downstream by Bcl-2.

Morales MC, Pérez-Yarza G, Rementería NN, Boyano MD, Apraiz A, Gómez-Muñoz A, Pérez-Andrés E, Asumendi A.

Free Radic Res. 2007 May;41(5):591-601.

PMID:
17454142
16.

H1 histamine receptor antagonists induce genotoxic and caspase-2-dependent apoptosis in human melanoma cells.

Jangi SM, Díaz-Pérez JL, Ochoa-Lizarralde B, Martín-Ruiz I, Asumendi A, Pérez-Yarza G, Gardeazabal J, Díaz-Ramón JL, Boyano MD.

Carcinogenesis. 2006 Sep;27(9):1787-96. Epub 2006 Mar 28.

PMID:
16569656
17.

Intracellular glutathione levels determine cell sensitivity to apoptosis induced by the antineoplasic agent N-(4-hydroxyphenyl) retinamide.

Morales MC, Pérez-Yarza G, Nieto-Rementeria N, Boyano MD, Jangi M, Atencia R, Asumendi A.

Anticancer Res. 2005 May-Jun;25(3B):1945-51.

18.

Structural and functional preservation of specific sequences of DNA and mRNA in apoptotic bodies from ES cells.

Andollo N, Boyano MD, Andrade R, Zalduendo MM, Eguizabal C, Asumendi A, Arlucea J, Aréchaga J.

Apoptosis. 2005 Mar;10(2):417-28.

PMID:
15843902
19.

Apoptosis of human T-cell acute lymphoblastic leukemia cells by diphenhydramine, an H1 histamine receptor antagonist.

Jangi SM, Asumendi A, Arlucea J, Nieto N, Perez-Yarza G, Morales MC, de la Fuente-Pinedo M, Boyano MD.

Oncol Res. 2004;14(7-8):363-72.

PMID:
15301427
20.

The chemopreventive agent N-(4-hydroxyphenyl)retinamide induces apoptosis through a mitochondrial pathway regulated by proteins from the Bcl-2 family.

Boya P, Morales MC, Gonzalez-Polo RA, Andreau K, Gourdier I, Perfettini JL, Larochette N, Deniaud A, Baran-Marszak F, Fagard R, Feuillard J, Asumendi A, Raphael M, Pau B, Brenner C, Kroemer G.

Oncogene. 2003 Sep 18;22(40):6220-30.

PMID:
13679861
21.

New benzo(b)thiophenesulphonamide 1,1-dioxide derivatives induce a reactive oxygen species-mediated process of apoptosis in tumour cells.

Alonso MM, Asumendi A, Villar J, Gil MJ, Martínez-Merino V, Encío IJ, Migliaccio M.

Oncogene. 2003 Jun 12;22(24):3759-69.

PMID:
12802283
22.

Implication of mitochondria-derived ROS and cardiolipin peroxidation in N-(4-hydroxyphenyl)retinamide-induced apoptosis.

Asumendi A, Morales MC, Alvarez A, Aréchaga J, Pérez-Yarza G.

Br J Cancer. 2002 Jun 17;86(12):1951-6.

23.

Morphological and Biochemical Characterization of a Cell Death Process Induced by E3, a New Synthetic Diarylsulfonilurea Analogue.

Alonso M, Miglaccio M, Encío I, Asumendi A, Martinez-Merino V, Hilario E, García M.

ScientificWorldJournal. 2001 Dec 1;1:50. doi: 10.1100/tsw.2001.179. eCollection 2001. No abstract available.

24.

Chromatin Structure and U2AF1-RS1 Gene Expression in Embryonic Stem Cells following RA-Induced Apoptosis.

Andollo N, Boyano MD, Garcia-Sanz M, Asumendi A, Zalduendo MM, Arechaga J.

ScientificWorldJournal. 2001 Nov 8;1:37. doi: 10.1100/tsw.2001.155. eCollection 2001. No abstract available.

25.

The role of cleavage of cell structures during apoptosis.

Asumendi A, Andollo N, Boyano MD, Hilario E, Perez-Yarza G, Atencia R, Arechaga J, García-Sanz M.

Cell Mol Biol (Noisy-le-grand). 2000 Feb;46(1):1-11.

PMID:
10726967
26.

Role of cytoskeleton in apoptosis.

Atencia R, Asumendi A, García-Sanz M.

Vitam Horm. 2000;58:267-97. Review.

PMID:
10668402
27.

Hepatic sinusoidal endothelium heterogeneity with respect to mannose receptor activity is interleukin-1 dependent.

Asumendi A, Alvarez A, Martinez I, Smedsrød B, Vidal-Vanaclocha F.

Hepatology. 1996 Jun;23(6):1521-9.

PMID:
8675173
28.

Interleukin 1 (IL-1)-dependent melanoma hepatic metastasis in vivo; increased endothelial adherence by IL-1-induced mannose receptors and growth factor production in vitro.

Vidal-Vanaclocha F, Alvarez A, Asumendi A, Urcelay B, Tonino P, Dinarello CA.

J Natl Cancer Inst. 1996 Feb 21;88(3-4):198-205.

PMID:
8632494
29.

Cytoarchitectural changes during retinoic acid-induced apoptosis in F9 embryonal carcinoma cells.

García-Sanz M, Atencia R, Pérez-Yarza G, Asumendi A, Hilario E, Arechaga J.

Int J Dev Biol. 1996;Suppl 1:195S-196S. No abstract available.

30.

Differential cytokine-mediated modulation of endocytosis in rat liver endothelial cells.

Martinez I, Sveinbjørnsson B, Vidal-Vanaclocha F, Asumendi A, Smedsrød B.

Biochem Biophys Res Commun. 1995 Jul 6;212(1):235-41.

PMID:
7612012
31.

Interleukin-1 receptor blockade reduces the number and size of murine B16 melanoma hepatic metastases.

Vidal-Vanaclocha F, Amézaga C, Asumendi A, Kaplanski G, Dinarello CA.

Cancer Res. 1994 May 15;54(10):2667-72.

32.

Isolation and enrichment of two sublobular compartment-specific endothelial cell subpopulations from liver sinusoids.

Vidal-Vanaclocha F, Rocha M, Asumendi A, Barberá-Guillem E.

Hepatology. 1993 Aug;18(2):328-39.

PMID:
8340061
33.

Role of periportal and perivenous sinusoidal endothelial cells in hepatic homing of blood and metastatic cancer cells.

Vidal-Vanaclocha F, Rocha MA, Asumendi A, Barberá-Guillem E.

Semin Liver Dis. 1993 Feb;13(1):60-71. Review. No abstract available.

PMID:
8446909

Supplemental Content

Loading ...
Support Center